Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Sales of Investments

Cash received from selling or redeeming investments.

Nakamoto Inc.NASDAQ: NAKA

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments outflow grows to $11.14M

Q1 FY2026 sales of investments was $11.14M, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $17.42M.

Context

  • Sales of investments amounted to 277.4% of revenue in FY2025, up 277.4 pp from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near $11.14M or moves back toward the trailing-twelve-month quarterly average of $4.35M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.14M+77.5% QoQ
Last fiscal yearDec 2025
$5.05M— YoY
LTMMar 2026
$17.42M— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
5.05M USD
Year-over-year change
—

Sales of Investments vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 sales of investments of $17.42M is the 8th largest of the 11 companies compared; the peer median is $143.45M.
  • Sales of investments amounts to 444.3% of revenue for NAKA, versus a peer median of 73.2%.
NAKA Competitors Peer median
Sales of Investments for NAKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LYELLyell Immunopharma, Inc.LTM Mar 2026$275.21M -52.0%-3.7%887777.4%
AMRNAmarin Corporation plcLTM Mar 2026$196.48M -13.0%-6.6%91.4%
CLLSCellectis S.A.LTM Mar 2026$194.21M +230.8%+921.3%285.2%
AGLAgilon Health, Inc.LTM Mar 2026$180.96M +7.9%+54.5%3.1%
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$146M -24.5%+62.7%—
DHDefinitive Healthcare Corp.LTM Mar 2026$140.89M -57.7%+15.2%59.1%
DCTHDelcath Systems, Inc.LTM Mar 2026$78.93M +87.6%—87.3%
NAKANakamoto Inc.LTM Mar 2026$17.42M ——444.3%
SLPSimulations Plus, Inc.LTM Feb 2026$11.9M -85.9%-48.4%14.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$0 ——0.0%
DBVTDBV Technologies S.A.LTM Mar 2026$0 -100.0%——
Peer median (excluding NAKA) $143.45M-24.5%+15.2%73.2%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
Deferred Income Tax00000
Stock-Based Compensation02.22M414.69K240.92K2.36M
Change in Working Capital(91.29K)33.23K116.36K(301.97K)(4.05M)
Accounts Receivables401(7.12K)(15.88K)(40.96K)0
Inventory(30.64K)10.2K(13.63K)58.9K0
Accounts Payables0122.31K163.55K(6.09K)(1.95M)
Other Working Capital(61.05K)(92.16K)(17.68K)(313.82K)(2.1M)
Other Non-Cash Items128.63K433.7K384.48K30.17M
Operating Cash Flow121.44K(140.38K)(449.49K)(3.07M)(23.51M)
Capital Expenditures(63.6K)(317.39K)(14.42K)(401.63K)(234.38K)
Acquisitions (Net)0000(29.82M)
Purchases of Investments00000
Sales of Investments00005.05M
Other Investing Activities000(388.34K)(655.02M)
Investing Cash Flow(63.6K)(317.39K)(14.42K)(401.63K)(680.02M)
Debt Repayment(47.34K)150K802.49K(614.86K)191.21M
Common Stock Issued2K400K05.86M523.74M
Common Stock Repurchased000(22.15K)(320.4K)
Dividends Paid00000
Other Financing Activities00009.22M
Financing Cash Flow(45.34K)550K802.49K5.22M723.85M
Effect of Forex Changes82.19K0000
Net Change in Cash94.69K92.23K338.58K1.75M20.31M
Free Cash Flow57.84K(457.77K)(463.91K)(3.48M)(23.75M)

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.